How do the benefits of epirubicin against breast cancer stack up against the risk of late-onset heart failure?
A biomarker of myocardial strain and inflammation may be able to discriminate between two similar pulmonary emergencies.
Test your recall of the most recent amendments to the heart failure guidelines on prevention, treatment of hypertension, and comorbidities.
Methamphetamine abuse is on a steady rise in the US. A new study highlights the nature and dangers of Meth-PAH.
Results of this study suggest a role for the anti-inflammatory diet in secondary prevention.
When both heart and kidney succumb to hypertensive damage, results are often devastating. Pickering syndrome is a case in point.
A new study supports the utility of pulmonary arterial proportional pulse pressure to predict 5-year mortality in patients with PAH.
The spectrum of hypertensive heart disease is broad. Try these 2 questions to help sharpen your focus on points along the disease continuum.
Beta-blockers may decrease FEV1 but have shown remarkable benefits in COPD patients. True or False?
While the strength of evidence for this "protective" effect is low, observers support further comparative effectiveness research in these patient groups.